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CHAPTER 1
INTRODUCTION
All living organisms contain certain chemicals which are essential for living. Based on their
relative amount in cells, these have been categorized into four major groups: (1) Bulk elements,
(2) Macrominerals and ions, (3) Trace elements, (4) Ultratrace elements. 1
Table 1.1 Selected chemical elements in the human body1.
Elements

Category

Percentage (by weight)

Oxygen

Bulk

53.6

Carbon

Bulk

16.0

Sodium, potassium

Macrominerals

0.10

Chlorine

Macrominerals

0.09

Iron

Trace elements

0.005

Zinc

Trace elements

0.003

Copper

Trace elements

2 X 10-4

Manganese

Ultratrace elements

2 X 10-5

Lead

Ultratrace elements

9 X 10-6

Though each type of element is present in vastly different amounts they all play important
roles in organisms. Bulk elements (O, C, N, H, P, and S) make up the basic composition for all
the compounds necessary for organisms. Macrominerals such as sodium, potassium, magnesium,
calcium, chlorine, and phosphorus provide essential ions to maintain osmotic balance or are
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components of structural elements for organisms. Trace elements including iron, copper, zinc,
are present in small amounts, and usually act as structural elements of enzymes in organisms or
as catalytic cofactors. Ultratrace elements like manganese, nickel, and cobalt, which are present
at less than 0.0001% by weight, play important roles in metabolism for organisms2.
1.1 Transition metal homeostasis
Transition metals are a group of metals many of which can exist in several oxidation states,
and usually participate in many important biological processes. They can act as electron carriers,
and catalyze oxygen transport as well as key steps in enzyme catalysis. Transition metal such as
Mn, Fe, Cu have several redox states, so they can serve as carriers for electron transfer reactions1.
Transition metals are essential for all living organisms. Most of the trace elements and ultratrace
elements are transition metals, such as iron, copper, zinc, and nickel1. Iron is the most abundant
metal in eukaryotes, bacteria, and archaea: it serves as a cofactor in respiration and as a structural
element in many proteins3. Zinc is another common transition metal for living organisms: it
operates as a structural element to maintain proper protein folding; also it is important in gene
regulation3. Nickel is usually present as a component of key enzymes for the final step of
methane production in bacteria4.
Living organisms need transition metals for their metabolism and other biological
processes; however, the concentration of transition metals in living organisms is usually tightly
regulated in a narrow range, since excess transition metals are also toxic for organisms and can
cause serious problems. Free metals ions are present under excess conditions; excess of a
specific metal ion may affect uptake of another metal, and then affect its role in biological
processes; some redox-active metals may cause oxidative damage for organisms when in
excess1,4,7,8.
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When plants are under metal deficiency conditions, they increase metal uptake by
activating high-affinity transporters and modifying the pathways for metal distribution. In
contrast, when metals are in excess, plants will activate the mechanisms for intracellular
chelation, compartmentalization, and expression of metallothioneins6.
Transition metals are also important for human beings. They act as cofactors for many
key processes in the body, such as respiration, and serve as structural elements and catalytic
centers for many key enzymes. Both deficiency and excess of metals cause many human diseases.
For example, hemochromatosis is due to iron overload, while thrombocytosis results from iron
deficiency. In order to maintain the optimum level of transition metals in the body, mechanisms
of metal chelation, metal uptake, metal storage, and metal trafficking are involved in this
complex process5.
1.2 Biology of Zinc
Zinc is a widespread element in living organisms, and it is the only transition metal to
exist in all six classes of enzymes. Zinc is an essential component of more than 300 enzymes,
which play critical roles in cell division, growth and differentiation, programmed cell death, gene
transcription, biomembrane functioning and obviously many enzymatic activities and enzymatic
structures5.
Zinc plays three major roles in enzymes: catalytic, structural and regulatory roles5. Zinc
plays a catalytic role in many cell processes including DNA synthesis, normal growth, brain
development, behavioral response, reproduction, fetal development, membrane stability, bone
formation, and wound healing5, 6, 9. Zinc also plays structural and functional roles in proteins to
stabilize the protein fold, including proteins involved in DNA replication and reverse
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transcription5, 6, 9. For instance, in the transcription factors known as zinc finger proteins, a group
of proteins that have zinc finger motif, zinc is required to stabilize the structure. Zinc can
regulate protein stability and enzymatic activity as an activator or inhibitor. Zinc can also
modulate cellular signal transduction processes and modulate synaptic neurotransmission in Zncontaining neurons in the forebrain5.
In living organisms, zinc exists in a paradox situation in that zinc as an essential nutrient
plays important roles in many biological processes, while excess zinc is toxic since it is a potent
disrupter of cellular processes via the following mechanisms. Firstly, Zn(II) is a strong Lewis
acid and electron pair acceptor, compared to other intracellular metal ions except copper. Excess
Zn(II) can block copper absorption and the activity of copper related enzymes. Secondly, Zn(II)
can inhibit the formation of free radicals, so it can protect sulfhydryl groups. When the
intracellular concentration of Zn(II) increases to toxic levels, it prevents disulfide bonds
formation and disrupts the function of enzymes that need the help of disulfide bonds for structure
and function5, 6, 9, 10.
1.3 Zinc and Human Health
Zinc is ubiquitous in humans and is the second most abundant trace element in humans
after iron. In humans, the average amount of Zn in adults is 1.4-2.3g, and the zinc concentration
in plasma is 12-16μM11. Most of the zinc is distributed in muscle, brain, skin, bones, kidney,
and liver. About 85% of whole body zinc is present in muscle and brain, and about 11% exists in
skin and liver5. Recent studies showed that about 10% of proteins in the human genome
potentially bind zinc, and zinc is a cofactor for more than 300 enzymes in humans5, 9.
Given the significance of zinc, disruption of zinc homeostasis leads to serious health
problems in humans (Figure1.1). Zinc deficiency can lead to growth retardation, defects in
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reproductive organs, dysfunction of the immune system and cognitive problems12. Zinc
deprivation can cause symptoms such as anorexia, loss of appetite, smell and taste failure, and
may affect the immune system, triggering arteriosclerosis and anemia5. Increasing evidence
shows that zinc deficiency is also involved in immunity disorders and in diseases such as cancer,
diabetes, depression, as well as Wilson’s disease, Alzheimer’s disease, and other age-related
diseases. Studies on mice suggest that dietary zinc supplementation prevents early onset diabetes
in mice, and patients with Type 1 diabetes have significantly low intracellular zinc levels13, 14.
Although zinc is important for the human body and lack of zinc can lead to serious health
problems, excess zinc is also harmful for humans. As discussed above, excessive zinc absorption
will lead to copper deficiency, since zinc can suppress the absorption of copper15. It is known
that a large amount of zinc exists in glutamate synaptic vesicles in the mammalian forebrain.
This zinc is released along with glutamate into the synaptic cleft during neuronal activity, and
then taken up by post-synaptic cells. Long-term exposure to excess zinc will be toxic and
damage the adjacent neurons16. Excess zinc is also involved in Alzheimer’s disease (AD). Zinc is
essential for enzymatic nonamyloidogenic processing of the amyloid precursor protein (APP)
and enzymatic degradation of the amyloid-β (Aβ) peptide. Zinc can bind to Aβ and promote
its aggregation and precipitation resulting in synaptic and memory deficits17. Chelation of zinc
has shown to reduce the formation of Aβ plaques in animal studies18.

6

Figure1.1: Comparison of the effects of zinc excess vs. zinc deficiency in the human body.
Excess of zinc and deprivation of zinc are both harmful for different organ systems12.
1.4 Cellular Zinc Homeostasis
Since zinc plays various roles in organisms, zinc levels are tightly regulated in cells. So
what is the zinc level in cells? O' Halloran first proposed the ―zinc quota‖, which is defined as
the total zinc content required for its optimum growth21. The zinc quota of Escherichia coli is
about 105 atoms of zinc per cell. In yeast, the zinc quota is about 107 atoms of zinc per cell. For
some mammalian cell cultures the zinc requirement is about 108 atoms per cell for cell growth22,

7

23, 24

. Thus the zinc quota for different cell types is quite different. However, when the volume of

these three different cell types is adjusted, the zinc concentration is similar, 0.1 to 0.5 mM27.
However, this is not always true. Certain types of cells such as some neurons, and prostate cells,
have higher zinc concentration than other tissues; this may reflect the fact that zinc has a
specialized role in these types of cells25, 26.
From the data above, we know that cells can tightly control intracellular zinc level; but
how do they do that? There is an extensive network of processes for regulation of intracellular
zinc, which is carried out by zinc importers and exporters, cellular ligands, and transcription
factors27. Since the regulation system of zinc homeostasis is not the same in eukaryotic and
prokaryotic cells, I will describe them separately.
In eukaryotic cells, transporters, cellular ligands, and transcription factors are all involved
in the process of regulation of intracellular zinc homeostasis27. For the situation of zinc repletion,
cells can down-regulate zinc importers, increase the expression of zinc exporters and store the
free zinc in loosely bound forms for future use, in order to keep the free zinc concentration at a
nontoxic level. During zinc deficiency conditions, eukaryotic cells will up-regulate high affinity
zinc importers, inhibit the expression of zinc exporters, and recruit the stored zinc to maintain the
structure and function of zinc bound proteins28. Some metallothioneins, which are a family of
proteins that can bind to free metals, serve as both gene transcription factors to regulate the
expression of transporters and cellular metal ligands to maintain intracellular zinc levels28. The
following Figure 1.2 shows the proposed intracellular zinc homeostasis regulation in yeast.
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Figure 1.2: Intracellular zinc homeostasis in S. cerevisiae. During zinc limiting conditions, Zap1,
a zinc-responsive activator protein, can up-regulate the expression of high affinity zinc importers
Zrt1 and Zrt2. Fet4 and Pho84 are low affinity broad spectrum transporters that can transport
other ions besides zinc. Zrt3, a vacuolar transporter, can facilitate zinc movement from vacuole
to cytosol to maintain cytosolic zinc levels. For zinc replete conditions, Cot1 and Zrc1,
transporters located on the vacuolar membrane, and Zhf located on the ER membrane, will
transport zinc from the cytosol to vacuoles or ER. ZIP family transporters are shown in blue and
CDF family transporters in red. Hypothetical and known transporters from other families are
shown in gray27.
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Figure 1.3: E. coli intracellular zinc homeostasis. Zinc homeostasis is mainly controlled by influx
and efflux transporters. Under deficiency conditions, Zur, a Fur homolog transcription activator,
activates the transcription of znuABC to up-regulate the high affinity zinc importer ZnuABC.
ZupT, which is a low affinity zinc importer also imports zinc to the cytoplasm. PitA, a low
affinity phosphate transporter, may also play a role in transporting zinc28. When E. coli is under
zinc stress, ZntA, ZitB, and YiiP work together to remove the excess zinc from the cytoplasm.
Ribosomal protein switches are also regulated by Zur to release zinc from other key cytosolic
metalloproteins. ZitB and YiiP are low affinity zinc exporters from the CDF family, while ZntA
is a high affinity zinc exporter from the P-type ATPase family. ZntR, a zinc sensor, regulates the
expression of ZntA29.
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In prokaryotic cells, intracellular zinc homeostasis is mainly regulated by import and
export systems that are regulated by their own transcription factors separately28. Storage
mechanisms are also involved in bacterial zinc homeostasis29. Bacterial cells need to be protected
against dramatic zinc concentration changes in the environment. Under zinc-limited situations,
bacterial cells will up-regulate and activate both high affinity and low affinity zinc importers.
Under zinc stress, the cells will export zinc by up-regulation of zinc exporters28, 29. E. coli is the
most popular prokaryotic model, and Figure 1.3 shows its intracellular zinc homeostasis.
1.5 Zinc Transporters
Zinc transporters are important for zinc homeostasis. Their role is to facilitate Zn
movement through the membranes, in order to maintain optimal Zn levels in cells. Zinc
transporters belong to different transporter families: RND multi-drug efﬂux transporters, P-type
ATPases, ABC transporters, the ZIP (Zrt-, Irt-like Protein) family, and the CDF (cation-diffusion
facilitators)/ZnT family of zinc transporters27, 28. However, these transporter families are not
ubiquitous. In eukaryotic cells, zinc transporters mainly come from the ZIP family and CDF/ZnT
families. RND transporters and ABC transporters have been reported to only exist in bacteria,
and only a few P-type ATPase family members play a role in transporting metal ions in
eukaryotes27, 28. Here, I will introduce these five transport families.
1.5.1 Mammalian Zinc transporter families
As mentioned above, mammalian zinc transporters mainly come from two families: ZIP
(Zrt- and Irt-like proteins) [solute-linked carrier 39 (SLC39)] and ZnT proteins [solute-linked
carrier 30 (SLC30)] 30. For humans, zinc transporters are named as SLC39A1 or SLC30A1, etc.
Members of these two families have opposite roles in cellular zinc homeostasis. Zip transporters
increase cytoplasm zinc levels by uptake of zinc from extracellular space or transporting
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vesicular zinc to the cytoplasm, while Znt transporters reduce intracellular zinc by exporting zinc
to extracellular space or organelles (Figure 1.4).

Figure 1.4 Mammalian zinc transporters. This figure shows the location and the function of some
key zinc transporters in a mammalian cell. The arrows also show the direction of zinc movement
for each transporter. As shown, the function of Zip and ZnT transporters is to increase and
decrease intracellular zinc concentration30, respectively.
1.5.1.1 ZIP Transporter family (SLC39)
The ZIP (Zrt, Irt-like protein) family is named after the first members discovered: IRT1
in Arabidopsis thaliana32, and ZRT1 and ZRT2 in Saccharomyces cerevisiae33, 34. Members from
this family are widely present in bacteria, fungi, archeae, plants and mammals31. The mammalian
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members in this family are also named as SLC3935. Members of the ZIP family play roles to
increase cytoplasmic zinc concentration by transporting zinc from extracellular space or
organellar lumen into the cytosol. ZIP transporters mainly transport zinc, however, they are also
involved in iron, manganese and cadmium transport30. There are fourteen zinc transporters
belonging to the ZIP family in humans (Figure 1.4). Most members in this family are predicted
to have eight transmembrane domains (TMDs) and similar topologies, with both N-terminal and
C-terminal ends of the protein located on the extracellular side of the membrane. Many members
have a long loop between TMDs 3 and 4, and a histidine-rich region is also located on this loop.
The function of this domain still not known, however, given the potential metal binding ability, it
may play a role in zinc binding or in regulation of transport30. Also the alignment result showing
sequence conservation on TMDs 4 and 5 suggests this may be the channel for passage of the
metal through the membrane30.
Based on sequence conservation, the ZIP family can be divided into four subfamilies： I,
II, LIV-1, and gufA31, 36. Members in subfamily I are mainly from fungal and plant sources,
while subfamily II consists of mammalian, nematode and insect genes. In humans, there are 4
zinc transporters belonging to these two subfamilies: hZIP9 belong to ZIP subfamily I, and
hZIP1, hZIP2, and hZIP3, all belong to ZIP subfamily II. Members in subfamily I and II are
predicted to have eight transmembrane domains, and the N-terminus and C-terminus of these
transporters are located outside the plasma membrane31, 36. There is a variable region present
between TMs 3 and TMs 4 of transporters from these subfamilies that is located in the cytoplasm.
This region has little sequence homology among the subfamily members, however, there is a
His-rich portion in this region which is predicted to be the zinc binding domain31, 36. Between
TMs IV and TMs V, there are two highly conserved portions that are amphipathic and contain
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conserved His residues among the members21, 37. These two portions are considered to form a
channel where the zinc ions can pass through and the conserved His residues or adjacent polar
residues serve as an extramembrane metal ion binding sites in these proteins37. In support of this
hypothesis, mutations of conserved His residues and adjacent polar residues in TMs IV and TMs
V of IRT1 were shown to abolish transporter activity38.
The LIV-1 subfamily, which is also named LZT (LIV-1 subfamily of ZIP
zinc Transporters),

is

distinguished

by

the

conserved

metalloprotease-like

sequence

HEXPHEXGD in TM V39. Members in this subfamily usually have a large N-terminal sequence
compared to other ZIP family members. However, the membrane topology of the LIV-1
subfamily is still in controversy. Some reports predict there are 6 to 8 TMs, some believe it is 7
TMs, but generally researchers believe it has 8 TMs like transporters from other subfamilies 39, 40,
41

. Currently there are 9 of human zinc transporters, hZIP4, hZIP5, hZIP6, hZIP7, hZUP8,

hZIP10, hZIP12, hZIP13, hZIP14, belonging to this family.
The last subfamily is the gufA subfamily, which is related to the gufA gene of
Myxococcus xanthus, and its function is still unknown. Only one human zinc transporter belongs
to this subfamily: hZIP11.
1.5.1.2 ZnT Transporter family (SLC30)
ZnT transporters are also named as CDF (cation-diffusion facilitators) transporters. ZnT
transporters have opposite roles compared to ZIP transporters; they serve to export intracellular
zinc to extracellular space or to organelles. Members belonging to this family come from diverse
organisms from fungi and bacteria to plants and mammals31, 36, 42-25. To date, more than 100
members are found to belong to this family, and there are 8 human zinc transporters belonging to
this family, ZnT1 to 830. Based on the sequence similarity, members in this family have been
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divided into three subfamilies, ZnT subfamily I, II, and III31. Subfamily I contains most of the
prokaryotic transporters, while subfamily II and III contain prokaryotic and eukaryotic
transporters, and all of the human ZnT transporters belong to subfamily II and III30. Most of ZnT
transporters have similar membrane topology with 6 transmembrane domains and both Cterminal and N-terminal domains on the cytoplasmic side. However, some of these transporters
are different from the majority, for example, hZnT5 has 15 transmembrane domains, and the
yeast MSC2 has 12 transmembrane domains31, 42, 46. Transporters in this family also have a Hisrich loop that is located between TMs IV and TMs V31, 42, 46. Additionally, TMs I, II, V, and VI
are amphipathic transmembrane domains, and have been predicted to be composed of an inner
core forming a channel and the remaining hydrophilic transmembrane domains III and IV are
located on the outer shell. The three highly conserved Asp residues in transmembrane domain II,
V, VI are predicted to be the zinc-binding site inside the channel42.
1.5.2 Bacterial Zinc transporter families
As mentioned above, Zinc transporters come from different transporter families: RND
transporters, P-type ATPase family, ABC transporters, the ZIP family, and the ZnT family

27, 28

.

In mammalian cells, the zinc transporters mainly belong to the ZIP and ZnT families. However,
in bacteria all of the above zinc transporter families have been shown to be involved in zinc
homeostasis. The ZIP and ZnT families have been introduced above; the other three zinc
transporter families are described below.
1.5.2.1 P-type ATPases family
P-type ATPases, named after a catalytic intermediate that is a key conserved aspartate
residue phosphorylated during the reaction cycle, is a large superfamily of integral membrane
proteins and are present in eukaryotes, archea and bacteria47,

48, 49

. Based on the sequence
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homology and substrate specificity, P-type ATPases are classified into five subfamilies, Type I
to Type V, and each subfamily is further classified into subgroups on the basis of substrate
specificity51, 58. They pump ions and lipids across cellular membranes to generate ion gradients,
which are important for a variety of cellular functions like signaling, energy storage and
secondary transport47, 48, 49. The first P-type pump, Na+/K+ ATPase, was discovered in the 1950s.
Through the years, many other pumps with similar characteristics have been discovered and
some of them are well studied and documented, such as Na+/K+ ATPase, Ca2+-ATPase, and
H+/K+ ATPase47, 48, 49. Studies on these pumps revealed many details about the structure and
mechanism of this transporter family. P-type ATPases contain functionally and structurally
distinct domains: a phosphorylation domain, an actuator domain, a nucleotide binding domain, a
transport domain, and class specific support domains50, 51.
The phosphorylation (P) domain as a central part of the cytoplasmic domain, is a highly
conserved domain among all the P-type ATPases, and it contains a DKTGTLT motif. An Asp
residue in this motif is phosphorylated reversibly during the ion transport. In the calcium pump,
the P-domain assembles into a seven-stranded parallel -sheet with eight helices forming a typical
Rossman fold50.
The actuator (A) domain is a highly conserved cytoplasmic domain; it contains the TGES
motif, which is a conserved motif involved in dephosphorylation of the phosphorylated
intermediate. Structural studies suggest that the domain contains a distorted jellyroll structure
and the TGES motif is located at the edge of this domain. During the ion transport process, the
A-domain especially the TGES motif, comes close in contact with the phosphorylation domain50,
51

.
The nucleotide binding (N) domain is essential for ATP binding and P-domain
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phosphorylation. The N-domain is connected to the P-domain by a narrow hinge50. It is the most
variable cytoplasmic domain compared to the P-domain and A-domain. Nevertheless, the core
structure of this domain is conserved51.
The transport (T) domain contains six membrane-spanning segments and protects the ion
binding sites, and is located halfway through the membrane. This domain moves during the
catalytic cycle to allow ions to associate and dissociate with the ion binding sites, so this domain
is highly flexible50, 52, 53.
The support (S) domain is a unit that can give structural support to the T-domain and has
specialized functions like providing ion-coordinating side chains as additional ion binding site in
some P-type ATPases such as Na+/K+-and Ca2+-ATPases. Compared to the T-domain, the Sdomain is more rigid, and does not change much during the catalytic cycle53.
Members of the P-type ATPases superfamily share a common mechanism for ion
pumping. Here, I will use Na+/K+ pump as a model to demonstrate the catalytic mechanism
(Figure 1.5). There are two distinct forms of the phosphorylated Na+/K+-ATPase 54, 55: one is the
phosphorylated form resulting from the addition of ATP and release ADP, E1-P (Enzyme1-P),
which is insensitive to K+; the other one is sensitive to K+ but not ADP, E2-P (Enzyme2-P) 56. E1
is phosphorylated to form E1-P when three intracellular Na+ ions bind to the pump and release
ADP. The phosphorylation leads to a conformational change in the pump to exposes the Na+ ions
to extracellular space. In the meantime, E1-P has low affinity for Na+ ions, so it releases the Na+
ions to extracellular space and the pump changes to the E2-P form. When two extracellular K+
ions bind to E2-P, E2-P will be dephosphorylated and revert to its previous conformation, E2, and
expose the K+ ions to intracellular space. The conformation reversal also lowers the affinity for
K+ ions. After releasing the K+ ions, the pump is back to E1 form again and ready to start another
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catalytic cycle57.

Figure 1.5 The catalytic cycle of Na+/K+ ATPase57. All P-type ATPases follow the same
mechanism as described above, and all domains work together to facilitate the ion transport.
1.5.2.2 RND (resistance-nodulation-cell division) transporter family
RND-driven tripartite protein complexes, which only exist in prokaryotes and not in
eukaryotes, can efflux a wide array of substrates. The RND (resistance-nodulation-cell division)
protein superfamily can be classified into seven protein subfamilies on the basis of substrate
specificity60. The RND transporters for Zn2+ are only found in few gram-negative bacteria28. For
example, CzcD protein of Ralstonia metallidurans is predicted to be first line of defense against
high concentrations of Zn2+, since the czcD mutant strain is slightly more sensitive to Zn2+ than
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the wild type strain59. The CzcABC complex can export zinc ions, cobalt ions, and cadmium ions,
across both cytoplasmic and outer membranes59.
1.5.2.3 ABC (ATP Binding Cassette) transporter family
ATP binding Cassette transporters exist in all species, and they transport ligands across
cellular lipid membranes, which is important for cell physiology. Transporters in this family can
import metal ions such as zinc; in addition, they are also involved in nutrient uptake, resistance
to cytotoxic drugs and antibiotics, and cholesterol and lipid trafficking27. ABC transporters are a
complex of three proteins, one or two of them are transmembrane proteins which can form a pore
in the membrane allowing specific substrates to pass through the membrane61. Energy from ATP
hydrolysis is required for the transport process62.
1.6 Zinc Transporters in E. coli.
Escherichia coli is a very good model system for zinc transporter studies. Our lab has
used this system to study metal transporters for several years. The reason we use this model
system is the whole genome of E. coli is well known and the strains are well adapted to the
laboratory environment. In addition, E. coli has both high-affinity and low-affinity transporters
working together to maintain the intracellular zinc homeostasis (Figure 1.3). There are four
major zinc transporters from four different transporter families in E. coli: ZntA, ZitB, ZupT, and
ZnuABC28, 29.
1.6.1 Zinc exporters in E. coli
E. coli has both a high-affinity exporter, ZntA, and a low-affinity exporter ZitB28. The
zinc transporting ATPase (ZntA) belongs to the P-type ATPase superfamily, and it was
originally identified by our lab71, 72, 73. When the intracellular zinc concentration is high, ZntR, a
zinc sensor, activates the expression of ZntA to transport the excess zinc to extracellular space 63.
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ZitB, a low-affinity zinc exporter, belong to the CDF family63. Sequence analysis and site
specific mutagenesis studies suggest residues His53, His159, Asp163 and Asp186 are important
for the transport process in ZitB63. Additionally, these residues are conserved in the CDF
transporter family, even when the specific substrates are different, suggesting these residues may
form a proton channel64.
1.6.2 Zinc importers in E. coli
E. coli also has both high-affinity and low-affinity zinc importers: ZnuABC and ZupT29.
ZnuABC, which belongs to the ABC transporter family, is induced by Zur, when the intracellular
zinc concentration is extremely low. ZnuABC is a protein complex consisting of ZnuA, ZnuB
and ZnuC. ZnuA is located on the periplasmic side, and binds to metal ions and ATP. ZnuB is
the membrane permease and ZnuC is the subunit responsible for ATP hydrolysis63. ZupT is a
low-affinity zinc importer, which belongs to the ZIP family19. ZupT is a broad-spectrum zinc
transporter, and can transport Fe2+, Co2+, Mn2+ and Cd2+, besides Zn2+ 19, 65.
1.7 Background of ZupT
ZupT is a cytoplasmic membrane protein, which is the first characterized ZIP family
member protein in bacteria. Grass’s report in 2002 showed that there is a low affinity zinc
transporter, ZupT, which is responsible for zinc uptake in E.coli19. In addition, as a member of
the ZIP transporter family, ZupT is a broad spectrum transporter that can transport iron and
cobalt besides zinc, and possibly manganese and cadmium18. Like other ZIP transporters, ZupT
is predicted to have eight transmemberane domains with both the N-terminal and C-terminal
ends of the protein located on the extracellular side of the membrane30 (Figure 1.6).
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Figure 1.6: Predicted structure of ZupT
ZupT is also involved in some human diseases, for example, urinary tract infection20.
ZnuABC and ZupT play important roles in bacterial growth in Zn limiting condition during
mouse urinary tract infection. The report also indicated that Znu was the primary zinc transporter,
and loss of Znu and ZupT has effects on fitness during UTI20.
Several reports had showed that ZupT is a broad spectrum metal transporter65. It can
transport iron besides zinc. E. coli strains with deletions in known iron uptake transporters were
created, and the strains could grow in presence of chelators when ZupT is expressed while other
iron importers were dysfuntional65. Transport was studied with the deletion strains. The results
suggested that ZupT can transport iron65. Similar experiments were done for Co2+, and the result
suggests that ZupT can mediate Co2+ uptake65. In addition, overexpression of ZupT makes the
strain hypersensitive to Co2+ and Mn2+ 65. All the results above suggest that ZupT is a broad
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spectrum metal transporter, and it can transport iron, cobalt and manganese besides zinc.
Transport studies from another group showed ZupT may also be involved in cadmium transport66.
Competition experiments with other substrate cations for ZupT suggested that ZupT has a
slight preference for Zn2+, and the kinetic parameters for zinc also support this observation66.
ZupT can also transport Cu2+

66

. Amino acid alignment results revealed several conserved

residues that are located on TMs V and TMs VI66. Site-specific mutagenesis has been done on
some residues. Mutants H89A lead to loss of the ability to transport Co2+ and Fe2+, while the
S117V mutant cannot transport Mn2+. In addition, E152D lost the activity to transport Zn2+ and
Mn2+66.
The studies mentioned above helped to solve a few of the mysteries about ZupT, however,
there are still many unsolved questions, such as metal binding, coordination, geometry and ion
selectivity of ZupT. My study will try to address some of these questions.
1.8 Background of PINA and ZntA-PINA
The pineal gland is a small endocrine gland in the brain, which is responsible for
melatonin synthesis and secretion at night69. Pineal night-specific ATPase (PINA) is a novel
splice variant of the ATP7B gene; defects in ATP7B cause Wilsons disease68. Wilsons disease is
an inherited disorder of copper transport, and leads to copper accumulation in tissues70. This
disease is due to mutations in the ATP7B gene, which encodes a copper transporting ATPase
belonging to the P1B subfamily of P-type ATPases. The sequence analysis result shows that PINA
is identical to the C-terminal portion of ATP7B68. Compared to ATP7B, PINA lacks the entire
N-terminal domain, which contains six CXXC motifs important in copper binding, as well as the
first four of eight transmembrane helices68. However, PINA still retains important domains of Ptype ATPases such as the phosphorylation domain, ATP binding domain, and the conserved CPC

22

motif. Indirect in vivo studies suggested that although the N-terminal copper binding region and
4 TMs are missing, PINA was still able to transport copper in yeast system but with much lower
activity68. So far, there is no direct evidence for transport activity of PINA.
ZntA, the high affinity zinc exporter in E. coli, another member of P1B subfamily of Ptype ATPases, can transport zinc, lead and cadmium67. ZntA has two metal binding sites, one is
in the N-terminal region and the other is in the transmembrane region67. ZntA also has eight
transmembrane domains, and since ZntA and ATP7B belong to the same subfamily, they may
share the same mechanisms for metal transport. Although our lab has studied ZntA for several
years, very little is known about the first four transmembrane helices. With the discovery of
PINA, we wanted to test a similar truncated transporter, PINA-ZntA, which lacks the N-terminal
domain and the first four transmembrane domains of ZntA, in order to investigate whether the
rest of the transporter is still functional or not.
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CHAPTER 2
INVESTIGATING THE METAL BINDING AFFINITY OF RECOMBINANT ZUPT
2.1 Purpose
As described in Chapter 1, ZupT belongs to the ZIP super family, members of which are
metal importers. Previous studies have all been indirect and showed that ZupT can transport zinc,
iron, cobalt, possibly cadmium, and manganese. However, the full metal selectivity for ZupT is
still unknown. Therefore, the purpose of this study is to express and purify the recombinant
protein, ZupT, in E. coli, and investigate its metal binding stoichiometry and affinity.
2.2 Materials
Plasmid pBAD/ myc hisC was purchased from Invitrogen. The ZupT pASK IBA3/JM83
strain was a gift from Dr. Sylvia Franke.
2.3 Methods
2.3.1 Construction of strep-tagged ZupT
ZupT strep (ZupT with a C-terminal eight residue-strep tag) was made by PCR using ZupT
pBAD myc hisC as template, and the forward primer 5’-CGG CCA TGG CAG TAC CTC TC 3’, and the reverse primer 5’-CGG AAT TCT TAT TTT TCG AAC TGC GGG TGG CTC CAA
CCA ATT CCC GC -3’. The PCR products and the pBAD myc hisC vector were digested with
NcoI and EcoRI, and purified by using Gene Clean kit, and then the two fragments were ligated
with T4 ligase. The ligation product was transformed into LMG194 competent cells. The
sequence was verified by DNA sequencing.
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Figure 2.1 ZupT with strep tag in pBAD myc hisC vector.
2.3.2 Mutants of ZupT in pASK IBA3 vector.
A sequence alignment of ZupT and homologues from other species was performed by using
CLUSTALW2 Multiple Sequence Alignment (European Bioinformatics Institute). The result
shows there are two highly conserved regions: one region is in the fourth transmembrane helix;
the other one is in the fifth transmembrane domain (Figure 2.2). Based on this observation, we
assume that those two regions may play a role in the metal transport process. In order to
investigate the metal binding sites, several ZupT mutants were created.
A previous lab member created four mutants H119N ZupT, E123Q ZupT, H148N ZupT, and
E152Q ZupT in pBAD vector with a C-terminal His-tag. Since I observed that the best protein
expression was from the ZupT pASK IBA3 construct (as explained later), I moved all the
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mutants to the pASK IBA3 vector. The four mutants were subcloned from the pBAD constructs
by PCR using the forward primer 5’- CCG AAT TCC TCA TTG TGA CCA TAC TGG C -3’
and the reverse primer 5’- GGG CCT GCA GAC CAA TTC CCG CCG -3’, used to create the
original pBad/ZupT clone. Then using the restriction enzymes EcoR1 and Pst1, the four PCR
products were cloned into pASK IBA3. The constructs were then transformed into JM83
competent cells, and their sequences verified with sequencing by genewiz.

Figure 2.2 Wild type ZupT in the pASK IBA3 vector.
2.3.3 Optimization of ZupT expression.
ZupT is a membrane protein, and previous studies in our lab suggested the expression
level for this protein is extremely low. Therefore, optimizing the ZupT expression was my first
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task. Several expression systems were used, together with the strains listed in table 2.1. First, all
the strains in the correct media were grown and each strain induced in mid-log phase with the
appropriate inducer. After the appropriate time for induction, the cells were harvested and the
expression level checked by western blotting.
Table 2.1 Different expression systems for ZupT.
Constructs

E. coli Strain

Media

LMG194

LB medium, LB medium+ Glycerol, M9

TOP10

medium, Auto induction

ZupT-Strep pBAD myc hisC
pSumo-ZupT

BL21
LB medium, LB medium+ Glycerol, M9
JM83
medium

ZupT pASK IBA3
BL21

Based on the western blotting result, I chose the best expression system, and then
optimized expression further by varying the OD600 at which the cells were induced, the
concentration of inducer, the induction temperature, and the induction time. Finally, the
expression was checked by western blotting.
2.3.4 ZupT expression and purification
A single colony was used from a freshly-streaked LB/Amp plate to inoculate 5ml LB culture
containing 100ug/ml ampicillin to OD600=0.10. 1ml of this culture was used to inoculate 125ml
LB culture with 100ug/ml ampicillin and grown overnight at 37℃. 10mL of the overnight
culture was inoculated in 1L freshly-prepared LB media, and grown at 37℃ about 3.5 hours until
the OD600 reach 0.8. The inducer, anhydrotetracycline (AHT), was added at this point (200ng/L)
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to the culture. After 4 hours induction, the final OD600 reached about 1.5. The cells were
harvested by centrifugation (8500 rpm, 10 min) and stored at -20℃ until further use.
The pellet was resuspended at 0.2g/mL in buffer A (25mM Tris-Cl pH7.0, 100mM
Sucrose, 1mM PMSF). The cells were lysed by passage through a French press twice at 20,000
p.s.i. The cell suspension was incubated with DNaseI (0.02mg/mL) and 2mM MgCl 2 at 4℃ for
40 minutes to degrade the chromosomal DNA. The cell debris was removed from lysed cells by
low speed centrifugation (7500rpm, 30 min) at 4℃. The broken cells were centrifuged at high
speed in an ultracentrifuge (45K rpm, 1h) at 4℃ to separate the membrane proteins from soluble
proteins. The membrane pellet was stored at 4℃ (short term) or -20 ℃ (long term) till further
use. The membrane pellet was resuspended in buffer B (25mM Tris-Cl pH7.0, 100mM Sucrose,
500mM NaCl, 1mM PMSF, 1mM 2-BME) to OD280= 100, then Triton X-100 was added to final
concentration 2% and the suspension stirred at 4℃ for 1h. After solubilization, the suspension
was centrifuged (45Krpm, 40min) to remove the insoluble fractions from solubilized proteins.
The supernatant from the second ultracentrifugation was then loaded on a Ni2+-resin column preequilibrium with buffer C (25mM Tris-Cl pH7.0, 100mM Sucrose, 500mM NaCl, 1mM PMSF,
1mM 2-BME, 2mM DDM). The column was then washed consecutively with 5 column volumes
of buffer C, and 5 column volumes buffer C with 10mM imidazole, and then the protein was
eluted with 3 column volumes buffer C with 50mM imidazole. The eluted protein fractions were
concentrated using 10K centricons, and then loaded onto the strep-tactin column pre-equilibrated
with NP buffer (50mM NaH2PO4 pH8.0, 300mM NaCl, 2mM DDM). The column was washed
with 5 to 10 column volumes NP buffer, and then the protein eluted with 20mL NPD buffer (NP
buffer + 2.5mM desthiobiotin). 1mL fractions were collected, and the protein containing

28

fractions were checked using a crude Bicinchoninic acid assay (Sigma). Then all proteincontaining fractions were combined, and concentrated using centricons. In order to remove the
desthiobiotin, the concentrated protein was passed through a 20ml G-25 column with buffer D
(10mM Bis-tris pH7.0, 2mM DDM). Protein-containing fractions were collected, pooled and
concentrated again. 10% glycerol was added and aliquots of the protein stored at -80℃ till
further use.
2.3.5 Determination of protein concentration
Protein concentration was determined by using the bichinchonic acid assay with bovine
serum albumin as standard. The principal for the bichinchonic acid assay is that Cu2+ ion is
reduced by proteins to form Cu+ in alkaline condition. The amount of reduction is in direct
proportion to the amount of protein present, and Cu+ and bichinchonic acid form a purple-blue
complex, which has a maximum absorbance at 562nm. A standard curve is generated by using
different concentration of bovine serum albumin.
2.3.6 Determination of the stoichiometry of ZupT by ICP-MS
The purified ZupT-strep was used to determine the concentration by BCA. Then 10uM
ZupT-strep sample in buffer 10mM Bis-tris with 2mM DDM was incubated with 150uM Zn2+ at
4℃ for 1 hour. The excess metal was removed by two consecutive passages through a G-25 gel
filtration column. Protein-containing fractions were determined using BCA, and the fractions
collected and concentrated using 10K Da centricons. Protein concentration was determined again
by using the BCA assay. The sample was prepared by diluting the metal-bound protein solution
with 2% Nitric acid solution for ICP-MS analysis. The metal concentration was determined by
using a PE Sciex Elan 9000 ICP-MS instrument and with metal standards from VWR.
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2.3.7 Investigating metal Binding Affinity of ZupT by Fluorescence spectroscopy.
Protein samples were prepared in 10mM Bis-Tris buffer, pH7.0, containing 2mM DDM. All
buffers were made with metal-free water by passing the water through a Chelex 100 column to
remove free metal ions. The sample was excited at 290nm, and the emission scans were taken
from 295nm to 500nm. After each addition of metal solution, the sample was mixed and a scan
of the sample was recorded. The results were analyzed using KaleidaGraph software to get the fit
and determine the metal binding affinity.
2.3.8 Determination of Metal binding affinity of ZupT by Mag-fura-2
The samples were prepared as above. The protein concentration in these experiments was
20uM. First, spectra were recorded from 300nm to 500nm with ~20uM mag-fura2 in 10mM BisTris buffer, pH7.0. Then the protein was added to the sample to make the final concentration
~20uM, and the spectrum recorded again. Then aliquots of metal solution were added, and the
spectra recorded after each addition. The absorbance change at 366nm was plotted vs. metal
added, and the results analyzed using Dynafit to determine the metal binding affinity.
2.4 Results
2.4.1 ZupT Homology Alignment
The result of a homology alignment using CLUSTALW2 Multiple Sequence Alignment
(European Bioinformatics Institute) is shown in Figure 2.3. There are two conserved regions
found within the ZupT sequence from different species. These two conserved regions are located
in the fourth and fifth transmembrane helices.
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Figure 2.3 Result of a ZupT family sequence alignment, and the conserved regions are framed in
boxes.
2.4.2 Optimization of ZupT expression
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In our lab, we have several expression systems for ZupT without any affinity tag or with
a strep-tag. Table 2.1 lists all the constructs we have for ZupT. I decided to investigate the best
expression system for ZupT. As the Western blot results in Figure 2.4 indicate, the best protein
expression was from the ZupT pASK IBA3/JM83 in LB medium.

1

2

3

4*

5

Figure2.4 Western blot comparing ZupT expression from different systems.
Legend:
Line1: ZupT pASK IBA3/BL21 non-induced in LB medium
Line2: ZupT pASK IBA3/BL21 induced in LB medium
Line3: ZupT pASK IBA3/JM83 non-induced in LB medium
Line4*: ZupT pASK IBA3/JM83 induced in LB medium
Line5: ZupT pASK IBA3/JM83 induced in minimum medium

However, even with this optimized expression system, a clear target band on an SDS-PAGE gel
is still not visible (Figure 2.5).
Therefore, further optimization was attempted with different OD600 at induction, different
concentrations of inducer, different induction temperatures, and different induction times,
according to the scheme presented in Table 2.2.
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21.5K

12% gel

Figure 2.5 Different fractions of noninduced and induced ZupT pASK IBA3/JM83.
Legend:
Line1: Protein standard
Line2: Non-induced JM83 low speed supernatant
Line3: Induced JM83 low speed supernatant
Line4: Non-induced JM83 low speed pellet
Line5: Induced JM83 low speed pellet
Line6: Non-induced JM83 high speed supernatant
Line7: Induced JM83 high speed supernatant
Line8: Non-induced JM83 high speed pellet
Line9: Induced JM83 high speed pellet
Table 2.2 ZupT expression optimization gradient

Strain

WT
pASK

Induction
OD600

ZupT 0.4

Inducer
Induction time
(anhydrotetracycline Induction
(AHT))concentration temperature(℃) (hours)
(ug/L)
20

16

3, 4, 5

21

3, 4, 5
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IBA3/JM83

50

100

200

20

0.6

50

100

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5
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200

20

50

0.8

100

200

20
1.0

50

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5
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100

200

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

16

3, 4, 5

21

3, 4, 5

30

3, 4, 5

37

3, 4, 5

The expression level was then checked by western blotting, and part of the results are
shown in Figure 2.6. The results suggest that the best condition for this strain is induction at
OD600 around 0.8, with 200ug/L AHT inducer concentration, and 4 hours of induction at 37 ℃.
For all subsequent protein expression, these conditions were used.
1

2*

3

4

5*

6

Figure 2.6 Western blotting results for optimization of ZupT expression.
Legend:
Line1: ZupT pASK IBA3/JM83 induced at OD600=0.6, induction for 4 hrs at 37℃.
Line2: ZupT pASK IBA3/JM83 induced at OD600=0.8, induction for 4 hrs at 37℃.
Line3: ZupT pASK IBA3/JM83 induced at OD600=1.0, induction for 4 hrs at 37℃.
Line4: ZupT pASK IBA3/JM83 induced at OD600=0.8, induction for 3 hrs at 37℃.
Line5: ZupT pASK IBA3/JM83 induced at OD600=0.8, induction for 4 hrs at 37℃.
Line6: ZupT pASK IBA3/JM83 induce at OD600=0.8, induction for 5 hrs at 37℃.
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2.4.3 ZupT purification
Purification of ZupT proved to be the most difficult part of my project because of the low
expression levels. Using a single strep-tactin column, which is specific for any strep-tagged
protein, ZupT could not be purified to a high level. Figure 2.7 shows all the fractions during the
purification using a single step using a strep-tactin column.
1

2

3

4

5

Figure 2.7 SDS gel with the fractions from a ZupT purification using a single strep-tactin
column.
Legend:
Line1: High speed Supernatant after detergent solubilization
Line2: Protein standard
Line3: Strep-tactin flow-though
Line4: Strep-tactin wash
Line5: Final protein eluant

37

Next, I tried to add additional steps to the purification process: using a combination of a
DEAE-Sephacel anion exchange column and strep-tactin column (Figure 2.8), a combination of
a Co2+ affinity (Talon) column and strep-tactin column (Figure 2.9), and a combination of a
Ni2+affinity column and strep-tactin column (Figure 2.10). The combination of the DEAE
column and strep-tactin column (Figure2.8), and the combination of Talon column and streptactin column (Figure 2.9) did not give me good quality purified ZupT. However, the
combination of a Ni2+ column and strep-tactin column gave the best quality purification (Figure
2.10).
When I was developing the purification method, I tried a combination of Co2+ -binding
Talon column and a strep-tactin column. Surprisingly, I observed that ZupT did not bind to both
columns, but it could bind to either of them. The western blotting result (Figure 2.9B) showed
that ZupT can bind to the Co2+ Talon column. However, after elution it did not bind to the streptactin column. When I tried to reverse the order of the columns, strep-tactin first, followed by
Talon (Figure 2.9A), the protein could not bind to the Talon column. Perhaps the former result is
due a conformation change. When ZupT binds to Co2+, the conformation of ZupT may be
changed, and the strep-tag, which is located on the C-terminal end of ZupT, is trapped inside the
folded protein. Therefore, it is unable to bind to the strep-tactin column. Alternatively, and more
likely, the strep-tag may be cleaved off during binding and elution from a Co2+ column. It is
unclear in the reverse case, why the partially purified strep-tagged column does not have any
binding affinity to Co2+ resin. The affinity of ZupT for Co2+ should be investigated in the future.
2.4.4 Fluorescence methods to determine the metal-affinity of ZupT
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In order to determine the metal-binding affinity of ZupT, the intrinsic tryptophan
fluorescence quenching of ZupT when metal solution is added, was utilized. When the
environment around a tryptophan residue is changed due to metal binding at a nearby site, its
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9

10*

Figure 2.8 SDS gel with the fractions from the ZupT purification for the combination of
DEAE ion exchange column and strep-tactin column.
Legend:
Line1: Low speed supernatant
Line2: High speed supernatant after detergent solublization
Line3: Protein standard
Line4: DEAE flow-though
Line5: DEAE wash
Line6: DEAE 50mM NaCl wash
Line7: DEAE 200mM NaCl elution
Line8: Strep-tactin flow-though
Line9: Strep-tactin wash
Line10*: Purified ZupT
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4

5
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7

8

Figure 2.9A. SDS gel with fractions of ZupT purification of combination of Talon column and
strep-tactic column. Figure is the result for purification of Strep-tactin followed by Talon
column.

Legend:
Line1: High speed Supernatant
Line2: Protein standard
Line3: Strep-tactin flow-though
Line4: Strep-tactin wash
Line5: Strep-tactin eluant
Line6: Talon column flow through
Line7: Talon column wash
Line8: 20mM imidazole wash of the Talon column
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B: 1
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3

4

5
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9

10

Figure 2.9 B Western blotting results of fractions of ZupT purification of combination of Talon
column and strep-tactic column. Figure B is the result for purification of Talon column followed
by strep-tactin column.
Legend:
Line1: High speed supernatant
Line3: Talon column flow through
Line5:20mM imidazole wash
Line7: Strep-tactin flow through
Line9: Strep-tactin elute

Line2: Protein standards
Line4:5mM imidazole wash
Line6:75mM imidazole wash
Line8: Strep-tactin wash
Line10: Old ZupT –strep taged protein.
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Figure 2.10 SDS gel with the fractions from the ZupT purification of the combination of Ni 2+
column and strep-tactin column.
Legend:
Line1: protein standard
2+
Line2: Ni column flow-though
2+
Line3: Ni column wash
2+
Line4: Ni column 10mM imidazole wash
2+
Line5: Ni column 50mM imidazole wash
2+
Line6: Ni column 300mM imidazole wash
Line7: Strep-tactin flow-though
Line8: Strep-tactin wash
Line9*: Purified ZupT
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fluorescence signal may change. ZupT has two naturally occurring Trp residues, Trp 173 and
Trp189. Additionally, the strep tag introduces a third Trp residue at the C-terminus. In this
experiment 4uM ZupT in 10uM Bis-tris buffer pH7.0 was used and titrated with increasing
concentrations of Zn2+. The sample was excited at 290nm.

Figure 2.11 Emission spectrum of ZupT in the 300-500nm range with increasing amounts of
added Zn2+; the arrow shows the direction of fluorescence change.

The relative change in fluorescence emission at 330nm from Figure 2.11 was plotted vs.
Zn2+ concentration, and the data was fitted using Kaleidagraph software (Figure 2.12). The
results suggest that ZupT has only one binding site for zinc since the fluorescence quenching was
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essentially complete at one equivalent of added Zn2+, and the Kd of this site is in the low uM
range, 1.02 ±0.14 uM.

Figure 2.12 Plot of relative change in fluorescence emission at 330nm from Figure 2.11 above as
a function of the added zinc salt concentration.
2.4.5 Competition experiments using Mag-fura 2 as a metal-binding competitor of ZupT
Mag-fura2 is a metal indicator, and it has a peak around 366nm without metal ion bound.
This peak shifts from 366nm to 325nm when mag-fura2 is bound to divalent metal ions. This
indicator was chosen since the affinity results using fluorescence titrations above suggested that
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Mag-fura 2 appears to have comparable affinity for metals to ZupT73, 74, 75. In the presence of
Mag-fura2, Zn2+ and ZupT, Mag-fura2 and ZupT will both compete to bind the metal ion. In
order to determine the affinity of ZupT for zinc, the absorbance change at 366nm of mag-fura 2
was monitored in the presence of ZupT and increasing concentration of metal ions, and the data
was fitted for a one metal-binding site model to ZupT using DynaFit software (Figure 2.13)77, 78.
The Kd from this fit was 0.35 ± 0.09 uM. The Kd for the indicator, mag-fura 2 used in this fit was
20uM.

Figure 2.13 Plot the absorbance change at 366 nm of mag-fura-2, and the data was fitted using
Dynafit software77, 78.
2.4.6 Stoichiometry of ZupT using ICP-MS
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The stoichiometry of ZupT with Zn was determined to be 0.63±0.0, using a PE Sciex Elan
9000 ICP-MS instrument and with metal standards from VWR.
2.5 Discussion
As a result of this study, a successful purification method has been developed for
poorly-expressed membrane proteins that have an intrinsic metal-binding affinity. In this method,
a strep-tagged protein without any his-tag, but with low divalent metal affinity, can be purified
by using a combination of low affinity binding to Ni2+ columns first to remove many impurity
proteins, and then a strep-tactin column with the enriched target protein. The low affinity for the
Ni2+ column is either from the metal binding site, or from some his-rich region in the protein.
It was also observed that heating the protein samples to boiling before loading on SDS
gels resulted in protein aggregation and degradation. Many membrane proteins are affected in a
similar way; the effect for ZupT was particularly pronounced (Figure 2.13). This suggests that it
is possible that some of high molecular weight bands in Figure 2.10 for the purified ZupT sample,
may not be other impurity proteins, but perhaps oligomers of ZupT. Although I treated the
purified ZupT with simple dilution, DTT and even urea, the upper bands cannot be removed
(Figure 2.14). Therefore, if they are oligomers, the oligomers cannot be dissociated easily.
Optimization of ZupT expression was successfully achieved by doing a systematic study
to optimize four major expression conditions: induction OD600, inducer concentration, induction
temperature, and induction time. Figure2.5 and 2.6 shows the optimization protocol and part of
the western blotting result for optimization of ZupT expression. The western blotting result is
interesting: comparing induction after 3 hours, 4 hours, and 5 hours induction at 37℃, there was
a surprising difference in the level of protein expression. A reasonable explanation for this
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Figure 2.14 10% gel SDS gel result of different treatment of purified ZupT.
Legend:
Line1: 1 time dilution ZupT sample
Line2: 2 time dilution ZupT sample
Line3: 4 time dilution ZupT sample
Line4: 8 time dilution ZupT sample
Line5: Protein standard
Line6: ZupT+1mM DTT
Line7: ZupT+10mM DTT
Line8: ZupT+ 100mM Urea
Line9: ZupT+ 4M Urea

9
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phenomenon is that with 3 hour induction the protein is not expressed very much, 4 hour is the
optimum time for induction, after which bacterial proteases degrade most of the overexpressed
protein. It is possible that at 5 hours of induction, more ZupT is produced, which results in zinc
concentrations in the cytoplasm rising to toxic levels and therefore bacterial proteases degrade
the recombinant protein. Also, although colony selection and optimization had been shown to
better express His-tagged proteins with different expression systems, it did not work for ZupT
pASK IBA3/JM83. Not much difference in expression levels was observed between different
colonies in two completely separate experiments. It is likely that overexpression of this
transporter is not optimal for cell survival.
All the metal-binding experiments of ZupT were performed at neutral pH, which was
reported to be optimum for its binding efficiency66. The fluorescence study to measure metal
binding of ZupT suggests that ZupT only has one binding site for zinc, and the binding affinity
for this site is in the low uM range. The affinity obtained using a direct fluorescence titraion, ~1
uM, and a competition titration experiment using the indicator mag-fura 2, ~0.35 uM, were in
reasonable agreement of each otrher. Since ZupT is the low-affinity board spectrum metal
transporter that is constitutively expressed in E. coli, the binding affinity for zinc looks
reasonable. When the environmental zinc concentration is in the low micromolar range or higher,
ZupT is adequate for zinc uptake to the cytosol. However, when the environmental zinc
concentration is lower than the micromolar range, ZupT may not able to import zinc, and in this
case, the high affinity ZnuABC system is turned on, and used for zinc uptake. The ICP-MS
stoichiometry study shows that the stoichiometry of ZupT for Zn is about 0.64, which suggests
that there perhaps is one binding site for Zn on ZupT, a result also supported by the binding
studies. Usually for one binding site, the stoichiometry should be 1. However, for ZupT the Zn
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binding affinity is low, so some Zn may have dissociated during the sample preparation for ICP
measurement.
2.7 Further Directions
The importance of the ZIP transporter family is undeniable in all species. Since all the
site-specific mutants are ready, these can be now used to map the metal binding site. Also we can
determine the metal selectivity of ZupT by using Maga-fura2 indicator competition and
fluorescence experiments. The long-term objective of this study is to investigate the human zinc
transporters which are homologs of ZupT. If we can understand the basic transport mechanism of
ZupT, we can gain fundamental insights into the human zinc transporters.
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CHAPTER 3
INVESTIGATING THE METAL BINDING AFFINITY OF PINA-ZNTA
3.1 Purpose
As mentioned in chapter 1, Pineal night-specific ATPase (PINA) is a novel splice variant
of the ATP7B gene; defects in ATP7B cause Wilsons disease. Compared to ATP7B, PINA lacks
the entire N-terminal domain, which contains six CXXC motifs that are important in copper
binding, as well as the first four transmembrane helices. The purpose of this study was to test a
similar truncated version of ZntA, PINA-ZntA (Figure 3.1), which lacks the N-terminal domain
and the first four transmembrane domains, in order to investigate how the loss of the metalbinding N-terminal domain and the first four transmembrane helices affect the rest of the
transporter.
A: ZntA

B: ZntA-PINA

Figure 3.1 Predicted structure of ZntA(A) and PINA-ZntA(B).
3.2 Materials
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Plasmid pBAD/myc HisC and E. coli strain LMG194 were purchased from Invitrogen.
Strep-tactin resin was purchased from Qiagen.
3.3 Methods
3.3.1 Protein expression and purification of PINA-ZntA
The PINA-ZntA strep/pBAD myc HisC/LMG194 strain was made by a previous lab
member. A single colony from LB/Amp plate was used to inoculate 5ml LB culture containing
100ug/ml ampicillin to OD600=0.10. 1ml of this culture was used to inoculate 125ml LB culture
with 100ug/ml ampicillin and grown overnight at 37℃. 10mL of the overnight LB culture was
used to inoculate 1L fresh LB media, and grown at 37℃ for about 3.5 hours until the OD600
reached 1.0. Then the inducer 0.02% of L-arabinose was added to the culture. After 4 hours
induction, the final OD600 was still around 1.0. The cells were harvested by centrifugation (8500
rpm, 10 min) and the pellet was stored at -20℃ until further use. The pellet was resuspended at
0.2g/mL in buffer A (25mM Tris-Cl pH7.0, 100mM Sucrose, 1mM PMSF, 1mM EDTA and
1mM β-mercaptoethanol (BME)). The cells were lysed by passage through a French press twice
at 20,000 p.s.i. Then the cell suspension was incubated with DNaseI (0.02mg/mL) and 2mM
MgCl2 at 4℃ for 40 minutes to degrade the chromosomal DNA. The debris was removed from
the lysed cells by low speed centrifugation (7500rpm, 30 min) at 4℃. The supernatant from the
low speed centrifugation was centrifuged again in the ultracentrifuge (45K rpm, 1h) at 4℃ to
separate the membrane fractions from the soluble part. The pellet from this centrifugation was
then resuspended in low ionic strength buffer (1mM Tris-Cl pH7.0, 100mM sucrose, 1mM
EDTA, 1mM PMSF, and 1mM β-mercaptoethanol (BME)) to remove the F1-ATPase, and
stirred for 1hr at 4°C. The membrane solution was centrifuged again at 45,000 rpm for another 1
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hour. Finally, the membrane pellet was stored at 4℃ or -20℃ till further use. The pellet was
resuspended in buffer B (25mM Tris-Cl pH7.0, 100mM Sucrose, 500mM NaCl, 1mM PMSF,
1mM 2-BME) to OD280= 100, then Triton X-100 was added to a final concentration 1% and the
suspension stirred at 4℃ for 1h. After detergent solubilization, the suspension was centrifuged
(45Krpm, 40min) to remove the insoluble fractions from soluble proteins. The supernatant from
the ultracentrifugation was then loaded on a Ni2+ column pre-equilibrated with buffer C (25mM
Tris-Cl pH7.0, 100mM Sucrose, 500mM NaCl, 1mM PMSF, 1mM 2-BME, 1mM DDM). The
column was then washed with 5 column volumes buffer C, and then the protein containing
fractions were eluted with 3 column volumes buffer C with 100mM imidazole. The eluant was
concentrated using 30K centricons, and then loaded on a strep-tactin column pre-equilibrated
with buffer C. The column was washed with 5 to 10 column volumes buffer C, and then the
protein was eluted with 20mL buffer C containing 2.5mM desthiobiotin. 1mL fractions were
collected. Protein-containing fractions were combined and concentrated using centricons. In
order to remove the desthiobiotin, the protein was passed through a 20ml G-25 column with
buffer D (10mM Bis-tris pH7.0, 1mM DDM). The fractions were collected and assayed for
protein. All the fractions with protein were pooled and concentrated again using 30K centricons.
Finally, the protein solution was aliquoted and stored with 10% glycerol at -80℃ till further use.
3.3.2Determination of protein concentration
Protein concentration was determined by using bichinchonic acid assay with bovine serum
albumin as standard as discussed in 2.3.5.
3.3.3 Investigating Metal Binding Affinity of PINA-ZntA by Fluorescence spectroscopy.
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The protein, in 10mM Bis-Tris buffer pH7.0 containing 1mM DDM, was reduced with 1
mM TCEP for 1 h at 4 °C. The TCEP was removed from the protein solution by passage through
a G-25 column. All the buffers and metal solutions were made using metal free water by passing
the water through a Chelex 100 column to remove free metal ions. The protein sample was
excited at 290nm, and the emission scans were taken from 295nm to 500nm. The results were
analyzed using KaleidaGraph software to get the fit and determine the metal binding affinity.
3.3.4 Determination of Metal binding affinity of ZupT by Mag-fura-2
The samples were prepared as above. The protein concentration in these experiments was
10uM. First, spectra were recorded from 300nm to 500nm with ~20uM mag-fura2 in 10mM BisTris buffer, pH7.0. Then the protein was added to the sample to make the final concentration
~10uM, and the spectrum recorded again. Then aliquots of metal solution were added, and the
spectra recorded after each addition. The absorbance change at 366nm was plotted vs. metal
added, and the results analyzed using Dynafit to determine the metal binding affinity.
3.4 Results
3.4.1 Purification of PINA-ZntA
A previous lab member had trouble purifying PINA-ZntA. Since I was more successful
using a metal-affinity column together with the strep-tactin column for ZupT, I applied the same
method for PINA-ZntA, which was also a strep-tagged protein. With the combination of Ni2+
column and strep-tactin column, good quality purified PINA-ZntA could be obtained (Figure3.2).
3.4.2 Stoichiometry of metal binding to ZntA-PINA by ICP-MS76
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ICP-MS was used to determine whether ZntA-PINA bound metal ions and the stoichiometry
by a previous lab member, Sandhya Muralidharan76. It was observed that ZntA-PINA bound all
three metal ions, Pb2+, Cd2+, and Zn2+, and the stoichiometry was ~0.5 for all three ions.
1
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Figure 3.2 SDS gel with the fractions from the PINA-ZntA purification using a combination of
Ni2+ column and strep-tactin column.

Legend:
Line1: High speed Supernatant

Line2: High speed pellet

Line3:Ni flow-through
Line5: Strep flow-through
Line7: Purified Del231ZntA Strep

Line4:Ni wash
Line6: Strep wash
Line9: Protein standard

2+

2+

3.4.3 Investigating Metal Binding Affinity of PINA-ZntA by Fluorescence spectroscopy
In order to determine the metal-binding affinity of PINA-ZntA, the intrinsic tryptophan
fluorescence quenching of PINA-ZntA was utilized. 4uM PINA-ZntA in 10uM Bis-tris buffer
pH7.0, 5 uM TCEP and 1 mM DDM was used in this experiment. The sample was excited at
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290nm and the emission scans were taken from 295nm to 500nm. The following figure show the
result of fluorescence titration studies of ZntA-PINA with Pb2+ (Figure 3.3), Cd2+ (Figure 3.4),
and Zn2+ (Figure3.5)

Figure 3.3 Emission spectrum of ZntA- PINA in the 295-500nm range with increasing amounts
of added Pb2+; the arrow indicates the direction of fluorescence change.
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Figure 3.4 Emission spectrum of ZntA- PINA in the 295-500nm range with increasing amounts
of added Cd2+; there is no observation fluorescence change during the titration.
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Figure 3.5 Emission spectrum of ZntA- PINA in the 295-500nm range with increasing amounts
of added Zn2+, the fluorescence change during the zinc titration was not unidirectional.
Since a fluorescence change was observed for the Pb2+ titration, the fluorescence change
from Figure 3.3 was plotted vs. added metal concentration in Figure 3.6, and the result suggest
that ther stoichiometry of ZntAPINA for Pb2+ is ~0.5.

57

Figure 3.6 Plot of fluorescence change in fluorescence emission at 325nm from Figure 3.3 above
as a function of the added lead salt concentration.
3.4.4 Determination of Metal binding affinity of PINA-ZntA by Mag-fura-2
In order to determine the whether PINA-ZntA can bind to zinc and cadmium, mag-fura-2, metal
indicator, was used, and the absorbance change at 366nm of mag-fura 2 was monitored in the
presence of PINA-ZntA and increasing concentration of Zn2+ (Figure 3.6) and Cd2+ (Figure 3.7).
The data for PINA-ZntA with Zn2+ in Figure 3.6 was fitted using DynaFit software77, 78. The data
was fitted for a half metal-binding site model to PINA-ZntA:
2 PINA-ZntA + M2+ < ---- > (PINA-ZntA)2M2+
The Kd obtained from this fit was (1.5 ±0.3) x 10-13 M.
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Figure 3.7: Determination of Zn binding affinity of PINA-ZntA using competition titration with
mag-fura-2. The absorbance change at 366 nm was plotted, and the data was fitted using Dynafit
software77, 78.
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Figure3.8: Cadmium titration with mag-fura-2 with (red) or without PINA-ZntA present (blue).
As evident from Figure 3.7, there did not appear to be any binding of Cd2+ to PINA-ZntA,
contrary to our expectations. This was probably due to the protein having been oxidized,
resulting in loss of the binding site, during the experiment.
3.5 Discussion
WT ZntA-PINA-strep, a highly truncated protein, was expressed even more poorly than
ZupT. Also, with the single strep-tactin column it was hard to get good quality purified protein. I
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applied the purification method I developed for ZupT, to purify this protein and got really high
quality purified protein as shown in Figure 3.2.
Interestingly, though PINA-ZntA was expressed more poorly than ZupT, with the double
column purification method, I was able to obtain better purification than ZupT, though in very
low yield. One explanation for this difference is that PINA-ZntA is able to bind to the initial Ni2+
column with higher affinity compared to ZupT, and can be washed with higher concentrations of
imidazole, and therefore more impurity proteins can be removed at this step.
ZntA-PINA as a truncated transporter shows fluorescence change during fluorescence
studies with increasing amount of lead and zinc, but not cadmium. Zinc binding triggered a nonuniform fluorescence change, and cadmium titration did not trigger any change at all. However
earlier stoichiometry results indicated that ZntA-PINA can bind to both Zn2+ and Cd2+ as well as
Pb2+. This indicates that binding of Pb2+, Zn2+ and Cd2+ in PINA-ZntA lead to different changes
in the environment around the Trp residues, in contrast to ZntA itself
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. The ZntA-PINA

fluorescence study with Pb2+ also shows the half stoichiometry, which supports the previous
stoichiometry study results for ZntA-PINA with Pb2+.
The mag-fura-2 results (Figure 3.6 and Figure 3.7) showed that PINA-ZntA can bind to
Zn2+, but not Cd2+. However, in previous studies using ICP-MS73, PINA-ZntA does bind Cd2+. It
is possible that after removal of the excess TECP, the protein was oxidized during the titration
experiments for Cd2+.
The affinity of ZntA-PINA for metal ions was many orders of magnitude greater than that
of ZntA itself, with Kd obtained for ZntA-PINA in the range of 10-13 M as opposed to 10-8—10-9
M for the metal-binding site in the membrane in wild-type ZntA75. Also, the metal-binding site
in ZntA-PINA could only bind one metal ion per dimer, in contrast to ZntA with all eight
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transmembrane helices intact75. This indicates that the first four transmembrane helices, together
with the cytosolic portions that were removed in ZntA-PINA either contributes to a full metalbinding site, or helps to organize the structure of the transmembrane helices such that each
monomer can bind one metal ion. It is possible that in the PINA variant in humans, Cu+ ions are
bound much more tightly than in the full-length ATP7B protein. The physiological reason for
this is yet to be understood.
3.6 Further Direction
The fluorescence study shows that ZntA-PINA is able to bind metals but suggests that in
contrast to ZntA, the different metals may have different ligands in this truncated mutant, which
result in different changes in the environment around the Trp residues. Future studies will be
aimed at identifying the metal-binding residues for each metal ion, using site-specific
mutagenesis.
Studies for PINA-ZntA are also important in showing that PINA has metal-binding
capability. This indicates that the PINA splice variant of ATP7B in humans may also be able to
bind copper ions but with a much higher affinity.
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ABSTRACT
INVESTIGATING THE METAL BINDING AFFINITY OF BACTERIAL ZINC TRANSPORTERS:
ZUPT AND TRUNCATED ZNTA (ZNTA-PINA)
by
FEI NIE
August 2013
Advisor：Dr. Bharati Mitra
Major: Biochemistry and Molecular Biology
Degree: Master of Science
Zinc is essential trace elements for all living organisms and serves as cofactor and
structural cofactors for more than 300 enzymes. ZupT is one of the members of ZIP super family
of transporter proteins, which were identified as iron and zinc transporter in Eukaryotes at first.
However, recent evidence showed that some of members can also transport other metal ions,
such as manganese or cadmium, and ZIP proteins also exist in bacteria. ZupT is responsible for
zinc uptake in E. coli; however, its full metal selectivity is not yet characterized. In addition, the
mechanism of transport is also unknown. Therefore, my goal is to check the affinity of ZupT
with different metal ions, and try to define the metal binding site by testing different mutants.
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